These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6808366)

  • 1. [How many patients are needed for a therapeutic trial? A statistical viewpoint].
    Neiss A
    MMW Munch Med Wochenschr; 1982 May; 124(18):444-6. PubMed ID: 6808366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How many patients are needed for a therapeutic trial? Viewpoints of clinical research (author's transl)].
    Uberla KK
    MMW Munch Med Wochenschr; 1982 May; 124(18):437-40. PubMed ID: 6808364
    [No Abstract]   [Full Text] [Related]  

  • 4. A confirmatory strategy for therapeutic equivalence trials.
    Kieser M
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):388-90. PubMed ID: 7582393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
    Düsing R
    Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative clinical study of guanoxan and guanethidine].
    Veldeman W
    Brux Med; 1965 Jun; 45(24):673-9. PubMed ID: 5319770
    [No Abstract]   [Full Text] [Related]  

  • 7. The Australian National Blood Pressure Study: a therapeutic trial in mild hypertension.
    Aust Fam Physician; 1981 Apr; 10(4):234, 237-9. PubMed ID: 7018480
    [No Abstract]   [Full Text] [Related]  

  • 8. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
    Elliott WJ
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
    [No Abstract]   [Full Text] [Related]  

  • 9. The 1964 trial of antihypertensive treatment.
    Hamilton M
    J Hum Hypertens; 2005 Jun; 19(6):503. PubMed ID: 15759022
    [No Abstract]   [Full Text] [Related]  

  • 10. Large therapeutic studies in elderly patients with hypertension.
    Orozco-Valero M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S38-43. PubMed ID: 11986892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing hypertension in European patients with coronary artery disease: design, results, and clinical implications of INVEST.
    Pepine CJ; Conti CR
    Ital Heart J; 2004 Jun; 5(6):411-6. PubMed ID: 15320564
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical inference and the design of clinical trials.
    Berry DA
    Biomedicine; 1980 Feb; 32(1):4-7. PubMed ID: 7370380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of angiotensin II inhibitors in arterial hypertension: clinical trials and guidelines].
    Mancia G; Grassi G
    Ann Ital Med Int; 2000; 15(1):92-5. PubMed ID: 10842897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
    Zanchetti A; Mancia G; Black HR; Oparil S; Waeber B; Schmieder RE; Bakris GL; Messerli FH; Kjeldsen SE; Ruilope LM
    J Hypertens; 2009 Apr; 27(4):673-9. PubMed ID: 19516168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trial of the activity and therapeutic effectiveness of 3 drugs with diuretic and antihypertensive action].
    Tiberi F; Corinaldesi G
    Minerva Med; 1981 Jan; 72(2):95-100. PubMed ID: 7007928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence of the therapeutic effect of antihypertensive therapy: meta-analysis and meta-regression of randomized and controlled trials].
    Jovell AJ; Cappelleri JC
    Med Clin (Barc); 2000; 114 Suppl 2():28-33. PubMed ID: 10916803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive trials: all is not gold that glitters?
    Dal Palù C
    Ital Heart J; 2005 Nov; 6(11):869-73. PubMed ID: 16320919
    [No Abstract]   [Full Text] [Related]  

  • 20. The ASCOT trial: a closer look.
    Kaplan NM
    J Hypertens; 2006 Feb; 24(2):211-4. PubMed ID: 16508561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.